AMANDA WILLIAMS: Open Payments
NPI 1134732852 · SCARBOROUGH, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 60 payments from 12 companies in 2025. Trend: 2023 $2,069 · 2024 $2,412 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $475 |
| Regeneron Healthcare Solutions, Inc. | 20 | $457 |
| GENZYME CORPORATION | 10 | $276 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| Pharming Healthcare, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Amgen Inc. | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $24 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, AIRSUPRA, NUCALA, RUCONEST, XHANCE, NEFFY.
Industry payments across ME — which companies pay providers there.
